All comparisons
BMY vs MRK
Bristol-Myers Squibb Company vs Merck & Co., Inc.
Overview
BMYBristol-Myers Squibb Company
Score APrice
$60.16
Fair Value
$65.83
Upside
+9.4%
Conviction
10/10
MRKMerck & Co., Inc.
Score A+Price
$124.41
Fair Value
$157.52
Upside
+26.6%
Conviction
10/10
Valuation
BMY
Bear$54.14
Base$95.36
Bull$138.00
Fair Value$65.83
MRK
Bear$111.97
Base$154.62
Bull$186.56
Fair Value$157.52
Quality
BMY
Grade
C
Score
69/100
Classification
Value
Rating
Score A
MRK
Grade
A
Score
95/100
Classification
Compounder
Rating
Score A+
Company Info
| BMY | MRK | |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - General | Drug Manufacturers - General |
| Classification | Value | Compounder |
Verdict
MRK has better risk/reward
MRK: Higher upside potentialMRK: Better quality grade